Skip to main content
. 2022 Aug 12;20:360. doi: 10.1186/s12967-022-03561-x

Table 2.

Chi-square results: recurrent freebayes mutations expanded beyond tumor suppressors and oncogenes

graphic file with name 12967_2022_3561_Tab2_HTML.jpg

Patients in Group A experienced a higher CTCAE grade for late dysphagia compared to their early dysphagia. Patients in Group B experienced the same or lower CTCAE grade for early and late dysphagia. The effect value > 1 is the odds ratio for increased proportion of germline variants in Group A